Register entry
- Registered sites
- 1
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 1
- Base
- Argentina
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1Labelling1Packaging1particle size reduction1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| GADOR S.A. | Route 8, Km. 60, Street 10, Fraction III, Plot 6A, Pilar Industrial Park, Pilar, Buenos Aires B1630CFA, Argentina (ARG) | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging, particle size reduction | 3003276678978726727 |
Catalogue
Drug listings by form and route
33 active NDC listings: 3 bulk ingredient. By marketing category: BULK INGREDIENT 3.
| Dosage form | NDCs |
|---|---|
| powder | 3 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| gador s.a. | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Disodium Pamidronate | powder | 65797-0009BULK INGREDIENT |
| - | Norelgestromin | powder | 65797-0002BULK INGREDIENT |
| - | Zoledronic Acid | powder | 65797-0006BULK INGREDIENT |
Neighbours
Registered in the same town
2- Glenmark Pharmaceuticals Inc., USAPilar, ARG
- Umicore Argentina S.A.Pilar, ARG
Compare
Comparable companies in Argentina
- Maprimed S.A.1 site · 13 NDC
- Umicore Argentina S.A.1 site · 3 NDC
Enquiry
Common questions
- Is GADOR S.A. FDA approved?
- GADOR S.A. holds 1 FDA-registered establishment in Argentina. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are GADOR S.A.'s drugs manufactured?
- The FDA register lists Pilar. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, packaging, particle size reduction.
- What drugs does GADOR S.A. make?
- 3 products are listed under GADOR S.A. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.